by Gemma Escarré,
Banco Sabadell and Asabys Partners, founded by Josep Lluís Sanfeliu and Clara Campàs —member of the last Board of directors at CataloniaBio (2014-2018)—, have created a new venture capital fund of 60 million euros which will centre its investment activity in the health arena.
The new fund is known as Sabadell Asabys Health Innovation Fund. It will carry out initial investments in biotech, MedTech and digital health companies in Spain, as well as the UK and Israel.
The fund could obtain up to 6 million euros per company, and expects to work closely with research centres and benchmark hospitals.
Catalonia, an upward investment in health
Biomedical companies were able to attract €153.1 million in investment in 2016, a record figure for the sector, according to the Study on the investment in biomedicine in Catalonia edited by CataloniaBio & HealthTech in collaboration of EY. The investment data for the 2017 sector will be presented on June 12 in Barcelona.
BStartup Health Call
Parallel to this, Banco Sabadell is opening its BStartup Programme up to the health sector through a nationwide call in which three innovative projects in their early stages will receive an investment of €75,000 and a programme to support their progress in validating their technology and market, enabling them to access new rounds of financing.
Photo: Raúl Rodriguez, BS Capital, and Josep Lluís Sanfeliu, Asabys Partners - © Banc Sabadell